The 13th Asia Pacific Federation of Pharmacologist (APFP) Meeting

"New Paradigms in Pharmacology for Global Health"

Place:     Berkeley Hotel Pratunam,
             Bangkok
Date:      1st - 3rd February, 2016
Time:     09.00 a.m.- 04.00 p.m.
             The Pharmacological and Therapeutic Society of Thailand (PHAR THERST or PTST) is domestically, interconnected with other academic societies through the network of National Council of Sciences and Technology of Thailand. Internationally, PTST is a member of International Union of Basic and Clinical Pharmacology (IUPHAR). In addition PTST is also a member of Southeast Asian Western Pacific-Regional of Pharmacologists (SEAWP-RFP) which recently became The Asia Pacific Federation of Pharmacologists (APFP). PTST was honored to host the 3rd Conference of SEAWP-RFP in Bangkok in 1982 and it was pleasure to organize the 13th Asia Pacific Federation of Pharmacologists (APFP) Meeting in Bangkok during 1st - 3rd February 2016. Contributions from APFP, invited speakers and participants from over 20 countries are truly appreciated.
             The 13th Asia Pacific Federation of Pharmacologist Meeting under the theme of ‘New Paradigms in Pharmacology for Global Health’ which perfectly reflects the role of pharmacology in the crossroad of the ever changing scene in health care. Sixteen years into this millennium, we continue to witness vast advances in our understanding of how molecules interact at the subcellular level. We also witness a massive explosion of technologies that allow us to probe into the mysteries of human diseases. Pharmacology is an important discipline in biomedical science. It is the foundation of new drug discovery and development that has brought to mankind a longer and better quality of life, particularly since the explosion of this discipline during the last century and continue to do even more so into our present days. As the key discipline that interfaces fundamental investigation, clinical trial and health care, pharmacology again enjoys a unique position in contemporary medicine. To maintain this uniqueness, we pharmacologists must continue to inspire our younger generation to thrive to be innovative in establishing new paradigms in our discipline. This is the soul of this quadrennial gathering of senior and junior pharmacologist based in the Asia and Pacific region and beyond.
         Drug design and discovery is a global issue, and nations all over the world share the same challenges and concerns that surround this important topic. The conference can provide several interesting perspectives on the role of pharmacology in drug discovery and development research for important public health diseases. The deliberations and recommendations of this conference had provided a significant impact on the future directions of the discovery and development of new promising drugs and on the improvement towards the health and wellness of humanity.
          The Scientific Committee organized 18 symposiums, and oral and poster presentations. The program covered exciting issues related to the latest advances in drug discovery and development research. In addition, the conference also included Young Investigator Awards and Chaired Poster Presentation Competition. The congress was a unique opportunity to meet top ranking specialists of various professional backgrounds involved in drug discovery, drug development, pharmacology and pharmacotherapy as well as other related fields. It provided ample opportunities for exchanging novel scientific findings, initiating research collaborations and promoting friendship.
          These three conference days allowed academics, researchers and professionals to share their ideas and opinions, to discuss about an update in all aspects in Pharmacology and to establish personal contacts as well as generate international collaborations in the future.
Highlight
height= Pharmacogenomics in drug safety
height= Personalized and advanced medicine
height= Novel pharmacotherapy and drug discovery & development in many diseases
height= Standards & regulation in drug discovery & development for GCP and ethics